Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, Berlin, Germany.
Department of Immunology, Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.
Pediatr Allergy Immunol. 2022 May;33(5):e13778. doi: 10.1111/pai.13778.
Peanut and tree nut allergies are common in childhood and often severe in nature. The clinical picture shows a wide variety of symptoms.
To analyze the distribution of clinical symptoms and severity during oral food challenges (OFC) in children.
Analysis of 1.013 prospectively recorded, positive OFCs with peanut (n = 607), hazelnut (n = 266), walnut (n = 97), and cashew (n = 43). Symptoms were categorized as immediate-type skin, gastrointestinal, upper and lower respiratory, cardiovascular symptoms, and eczema exacerbation. Symptom severity and treatment were recorded.
Skin symptoms presented in 78%, followed by gastrointestinal (47%), upper (42%), and lower respiratory symptoms (32%). Cardiovascular symptoms presented in 6%. In three-quarter of the reactions, more than one organ was involved. Importantly, severe reactions occurred at every dose level. Peanut- and cashew-allergic patients had a higher relative risk of gastrointestinal symptoms compared with hazelnut- and walnut-allergic patients. Patients without vomiting had a 1.7 times higher risk developing immediate-type skin and/or lower respiratory symptoms. Three-quarter of the patients ever had eczema but worsening presented in only 10.5% of the OFCs. In patients with multiple food allergies, organs involved, eliciting dose and severity differed between allergens.
Although comparisons between allergen groups with different clinical history, severity, comorbidities and laboratory data are difficult and might contain bias, our data confirm the high allergenic potential of peanut and tree nuts. The rare occurrence of eczema worsening emphasizes that avoidance diets of peanuts and tree nuts to cure eczema seem to be unnecessary and may hamper tolerance maintenance.
花生和树坚果过敏在儿童中很常见,且通常较为严重。临床表现多种多样。
分析儿童口服食物激发试验(OFC)中临床症状和严重程度的分布。
对 1013 例经前瞻性记录证实的阳性 OFC 进行分析,其中包括花生(n=607)、榛子(n=266)、核桃(n=97)和腰果(n=43)。将症状分为即时型皮肤、胃肠道、上呼吸道、下呼吸道、心血管症状和湿疹加重。记录症状严重程度和治疗情况。
皮肤症状占 78%,其次是胃肠道(47%)、上呼吸道(42%)和下呼吸道(32%)。心血管症状占 6%。在四分之三的反应中,有一个以上的器官受累。重要的是,严重反应发生在每个剂量水平。与榛子和核桃过敏患者相比,花生和腰果过敏患者胃肠道症状的相对风险更高。无呕吐患者发生即时型皮肤和/或下呼吸道症状的风险增加 1.7 倍。四分之三的患者曾患有湿疹,但在 OFC 中仅 10.5%出现恶化。在患有多种食物过敏的患者中,过敏原之间受累器官、激发剂量和严重程度存在差异。
尽管比较具有不同临床病史、严重程度、合并症和实验室数据的过敏原组存在困难且可能存在偏倚,但我们的数据证实了花生和树坚果具有很高的致敏性。湿疹恶化罕见,这强调了避免食用花生和树坚果来治疗湿疹似乎是不必要的,并且可能会妨碍耐受维持。